Cognition research
Selank vs Semax
Two neuropeptide research compounds with different behavioural literature.
Overview
This comparison separates Selank and Semax for laboratory reference—not product selection.
Selank: Enhanced derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approved in Russi…
Semax: Enhanced and stabilized version of Russian nootropic Semax with superior stability, extended half-life, and enhanced bioavailability through acetylation and amidation modifications…
Key differences
- Selank is commonly discussed in anxiolytic and GABAergic modulation research.
- Semax is commonly discussed in neurotrophic and cognitive performance models.
Mechanistic differences
Selank: Enhanced derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Sela…
Semax: Enhanced and stabilized version of Russian nootropic Semax with superior stability, extended half-life, and enhanced bioavailability through acetylation and ami…
Pharmacology
Selank: Enhanced derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Sela…
Semax: Enhanced and stabilized version of Russian nootropic Semax with superior stability, extended half-life, and enhanced bioavailability through acetylation and ami…
Research focus
Selank: Tissue repair & recovery: Enhanced derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Pare…
Semax: Cognition & neuromodulation: Enhanced and stabilized version of Russian nootropic Semax with superior stability, extended half-life, and enhanced bioavailability through…
At a glance
Practical differentiation
- AXIOM does not provide dosing, administration, or protocol guidance.
- Catalogue links appear only where AXIOM lists a research-use product.
- Reference-only compounds remain comparison terms without implying availability.
References
- pubmed.ncbi.nlm.nih.gov/29798983/
- pubmed.ncbi.nlm.nih.gov/30225715/
- pubmed.ncbi.nlm.nih.gov/24661604/
- pubmed.ncbi.nlm.nih.gov/16996037/
- pubmed.ncbi.nlm.nih.gov/9173745/
FAQ
Does this page recommend Selank or Semax?
No. It is an editorial comparison for research context only.
Does AXIOM provide protocol guidance?
No. Protocol and dosing decisions belong with qualified laboratory teams and source literature.